Company Filing History:
Years Active: 2010-2011
Title: Marie Eskling: Innovator in Immunotherapeutics
Introduction
Marie Eskling is a prominent inventor based in Horsholm, Denmark. She has made significant contributions to the field of immunotherapeutics, particularly in the purification of EGFR family proteins. With a total of 2 patents, her work is paving the way for advancements in cancer treatment.
Latest Patents
Marie Eskling's latest patents include innovative methods for the purification of HER-2 variants. The first patent, titled "Immunogenic HER-2 variants," outlines a novel method for purifying EGFR family proteins obtained from cultures of insect cells. This process involves several steps, including diafiltration and exchange of culture medium with buffer, immobilized metal affinity chromatography (IMAC), size exclusion chromatography (SEC), and anion exchange chromatography (AIE). The patent also describes an immunogenic variant of the HER-2 protein, specifically adapted for this purification process. The second patent, "Purification of HER-2 variants," reiterates the same innovative purification method, emphasizing its importance in the field.
Career Highlights
Marie Eskling is currently associated with Bn Immunotherapeutics, Inc., where she continues to develop her groundbreaking work in immunotherapy. Her expertise in protein purification techniques has positioned her as a key player in the research and development of cancer treatments.
Collaborations
Marie collaborates with Klaus Gregorius Nielsen, enhancing her research efforts and contributing to the advancement of immunotherapeutic solutions.
Conclusion
Marie Eskling's innovative work in the purification of HER-2 variants showcases her dedication to improving cancer treatment methodologies. Her contributions are vital to the ongoing research in immunotherapeutics, and her patents reflect her commitment to advancing medical science.